AVITA Medical, Inc. (RCEL)
13.16
+0.12
(+0.92%)
USD |
NASDAQ |
Oct 19, 16:00
13.16
0.00 (0.00%)
After-Hours: 16:15
AVITA Medical Cash from Operations (Annual) : -31.20M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -31.20M |
| December 31, 2024 | -48.94M |
| December 31, 2023 | -38.01M |
| December 31, 2022 | -19.09M |
| June 30, 2021 | -25.90M |
| June 30, 2020 | -22.75M |
| June 30, 2019 | -19.66M |
| June 30, 2018 | -12.68M |
| June 30, 2017 | -6.454M |
| June 30, 2016 | -5.446M |
| June 30, 2015 | -5.337M |
| June 30, 2014 | -6.357M |
| June 30, 2013 | -7.438M |
| June 30, 2012 | -4.399M |
| Date | Value |
|---|---|
| June 30, 2011 | -2.883M |
| June 30, 2010 | -1.425M |
| June 30, 2009 | -3.448M |
| June 30, 2008 | -3.302M |
| June 30, 2007 | -7.044M |
| June 30, 2006 | -7.346M |
| June 30, 2005 | -9.202M |
| June 30, 2004 | -4.283M |
| June 30, 2003 | -0.5755M |
| December 31, 2002 | -1.032M |
| December 31, 2001 | -0.2996M |
| December 31, 2000 | -0.4712M |
| December 31, 1999 | -0.6204M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Halozyme Therapeutics, Inc. | 651.56M |
| Iovance Biotherapeutics, Inc. | -302.41M |
| Agenus, Inc. | -77.20M |
| Amgen, Inc. | 9.958B |
| Editas Medicine, Inc. | -165.24M |